Alicia C. Olivo - EVP, GC & Business Development at NEOGENOMICS INC

Insider Transactions and Holdings

Identity
Entity type
Individual
Issuer context
SEC evidence

Alicia C. Olivo - trading volume in the past year for NEOGENOMICS INC

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-25,834
Avg price
$11.62
Total value
-$300,172

Net

Past year
Shares
-25,834
Share %
-100%
Total value
-$300,172

Holdings reported by Alicia C. Olivo for NEOGENOMICS INC

Form 4 holding EVP, GC & Business Development

NEOGENOMICS INC

Security class
Stock Option (Right to Buy)
Shares / value
147,804
Estimated value
$1,214,948
Report date
11 May 2026
Price
$8.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount
147,804
Form 4 holding EVP, GC & Business Development

NEOGENOMICS INC

Security class
Common Stock
Shares / value
93,567
Estimated value
$694,267
Report date
11 May 2026
Price
$7.42
Ownership
Direct
Form 4 holding EVP, GC & Business Development

NEOGENOMICS INC

Security class
Performance Stock Unit
Shares / value
25,330
Estimated value
$208,212
Report date
11 May 2026
Price
$8.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,330
Form 4 holding EVP, GC & Business Development

NEOGENOMICS INC

Security class
Restricted Stock Unit
Shares / value
2,559
Estimated value
$21,034
Report date
11 May 2026
Price
$8.22
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,559

Transactions reported by Alicia C. Olivo for NEOGENOMICS INC

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .